Smell training in CRS patients with smell loss
Official title: Cognitive and Immunologic Profiles of Patients With Olfactory Dysfunction After Smell Training
Run by The Cleveland Clinic · NCT07681973 · Data updated 2026-11-12
This study tests whether a 3-month smell training program can improve smell function and related immune and mental health measures in adults with chronic rhinosinusitis and smell loss.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 52 (estimated) |
| Sponsor | The Cleveland Clinic Academic / other |
| Locations | 1 site (Cleveland, Ohio) |
| Status | Recruiting |
| Started | December 9, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | March 31, 2027 |
| Registry record updated | July 2, 2026 |
| Trial ID | NCT07681973 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with CRS with nasal polyps and documented smell loss, without autoimmune disease, ciliary disorders, cystic fibrosis, tumors, trauma-related smell loss, or unilateral polyps.
✕Probably not a fit
Individuals without CRS with nasal polyps or those whose smell loss is due to trauma or tumors may not benefit from this training.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with chronic rhinosinusitis with nasal polyps and smell loss will undergo a baseline assessment of smell function, mental health, disease severity, and immune markers, followed by a 3-month smell training program. A subset, including healthy controls, will provide comparison data and baseline measurements only. The study will analyze tissue and blood samples to find molecules linked to smell loss and explore potential links to cognition. Outcomes include changes in olfactory function, immune profile, and mental health after training. Control participants will not have follow-up testing beyond baseline.
Why it matters
Potential benefit: If successful, the training could offer a non-pharmacologic option to improve smell and related symptoms in CRS patients.
How similar studies have gone: Prior smell-training studies in CRS or smell loss have shown variable improvements, indicating potential but not conclusive benefit for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age less than 18 years-old * Present to rhinology clinic with CRS with nasal polyps * Sense of smell loss for any reason (other than trauma or tumor) Exclusion Criteria: * Patients \< 18 years of age * Individuals with unilateral nasal polyps * Autoimmune diseases * Ciliary disorders * Cystic fibrosis * Smell loss due to tumors or trauma
Where it's running
-
The Cleveland Clinic
Cleveland, Ohio, United States Recruiting
Study contacts
- Principal investigator: Mohamad Chaaban, MD — The Cleveland Clinic
- Study coordinator: John O'Neill
- Email: ONEILLJ2@ccf.org
- Phone: 4405062611
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Triamcinolone-loaded nanocapsules after endoscopic nasal surgery
This trial tests whether a triamcinolone acetonide–loaded nanocapsule spray is better than saline irrigation for healing after endoscopic nasal surgery in adults with chronic rhinosinusitis and nasal polyps.
-
PROPEL corticosteroid‑releasing sinus implants — IBUKI cohort
This project tests how safe and well PROPEL corticosteroid‑releasing sinus implants work for people in Japan with chronic rhinosinusitis who undergo endoscopic sinus surgery.
-
Lavender aromatherapy for anxiety and pain during awake ear, nose, and throat procedures
This tests whether lavender aromatherapy used during awake ear, nose, and throat clinic procedures can reduce anxiety and pain in adults.
-
Seawater nasal sprays for relief of nasal and sinus symptoms
This project will test four seawater nasal sprays to see if they help infants, children, adults, and pregnant or breastfeeding people with acute or chronic nasal and sinus symptoms.
-
VVN432 nasal spray safety and early testing in healthy adults and people with chronic rhinosinusitis
This will test whether VVN432 nasal spray is safe and how the body processes it in healthy adults and in people with chronic rhinosinusitis.
-
Collecting small nasal tissue samples to examine smell-sensing cells
This project will collect small nasal tissue samples to test how smell-sensing cells work in people with normal smell, smell loss, or Alzheimer's.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.